We think you have liked this presentation. If you wish to download it, please recommend it to your friends in any social system. Share buttons are a little bit lower. Thank you!
Presentation is loading. Please wait.
Published byMarvin Murphy
Modified over 5 years ago
Survival After Surgical Resection for Lung Cancer in Patients With Chronic Obstructive Pulmonary Disease Anders Bugge, MD, May Brit Lund, MD, PhD, Cathrine Brunborg, MS, Steinar Solberg, MD, PhD, Johny Kongerud, MD, PhD The Annals of Thoracic Surgery Volume 101, Issue 6, Pages (June 2016) DOI: /j.athoracsur Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
Fig 1 Surgically treated stage I and II lung cancer patients. (COPD = chronic obstructive pulmonary disease; GOLD = Global Initiative for Chronic Obstructive Lung Disease; NSCLC = non-small cell lung cancer.) The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
Fig 2 Overall survival after surgical intervention for non-small cell lung cancer in patients with mild and moderate (green line) or severe (red line) chronic obstructive pulmonary disease (COPD) and in those with normal lung function (blue line). The Annals of Thoracic Surgery , DOI: ( /j.athoracsur ) Copyright © 2016 The Society of Thoracic Surgeons Terms and Conditions
Jeffrey M. Griffin, MD, MS, Carolyn E. Reed, MD, Chadrick E
Elizabeth A. David, MD, David T
Jeffrey L. Port, MD, Robert J. Korst, MD, Paul C. Lee, MD, Amanda L
A Propensity-Matched Analysis of Wedge Resection and Stereotactic Body Radiotherapy for Early Stage Lung Cancer Jeffrey L. Port, MD, Bhupesh Parashar,
Complete Thoracic Mediastinal Lymphadenectomy Leads to a Higher Rate of Pathologically Proven N2 Disease in Patients With Non-Small Cell Lung Cancer
Thomas J. Birdas, MD, Richard P. M
Chronic Obstructive Pulmonary Disease Impact Upon Outcomes: The Veterans Affairs Randomized On/Off Bypass Trial G. Hossein Almassi, MD, A. Laurie Shroyer,
History of Multiple Previous Malignancies Should Not Be a Contraindication to the Surgical Resection of Lung Cancer Pierre-Benoit Pagès, MD, Pierre Mordant,
Preoperative Serum Fibrinogen Level Predicts Postoperative Pulmonary Complications After Lung Cancer Resection Suk-Won Song, MD, Hyun-Sung Lee, MD, Moon.
Melanie Subramanian, MD, Timothy McMurry, PhD, Bryan F
Comparison of Thoracoscopic Segmentectomy and Thoracoscopic Lobectomy for Small-Sized Stage IA Lung Cancer Chenxi Zhong, MD, Wentao Fang, MD, Teng Mao,
Chun Chieh Lin, PhD, MBA, Matthew P
Joshua E. Rosen, BASc, Hari B
Ravi Rajaram, MD, MSc, Jennifer L
Sarcomatoid Carcinoma of the Lung: A Predictor of Poor Prognosis
Tumor Necrosis as a Prognostic Factor for Stage IA Non-Small Cell Lung Cancer Seong Yong Park, MD, Hyun-Sung Lee, MD, PhD, Hee-Jin Jang, MD, Geon Kook.
Significance of P53 and Rb protein expression in surgically treated non-small cell lung cancers Yung-Chie Lee, MD, PhD, Yih-Leong Chang, MD, Shi-Ping.
Nirav S. Kapadia, MD, MS, Luca F. Valle, MD, Julie A
Oncologic Outcomes After Surgical Resection of Subcentimeter Non-Small Cell Lung Cancer Matthew J. Schuchert, MD, Arman Kilic, BS, Arjun Pennathur, MD,
Clinical Prognosis of Superior Versus Basal Segment Stage I Non-Small Cell Lung Cancer Yoshinori Handa, MD, Yasuhiro Tsutani, MD, PhD, Norifumi Tsubokawa,
© 2023 SlidePlayer.com Inc. All rights reserved.